LIMD1 and cardiac hypertrophy: Mechanistically, both in vivo and in vitro experiments demonstrated that overexpression of LIMD1 significantly inhibits the activation of the YAP1/AKT/GSK3β signaling pathway, thereby reversing pathological cardiac hypertrophy induced by pressure overload.